APRE
Aprea Therapeutics, Inc. Common stock
$0.65
-5.06%
-0.03
Notify me if price changes either direction
Buy APRE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
4.6M
Enterprise value
-8636327
Trailing PE
0.47928512
Forward PE
-0.92617446
PEG Ratio
-0.018043675105882
Enterprise to EBITDA
0.626
Enterprise to revenue
-17.689
Price to book MRQ
0.3780822
Price to sales TTM
9.883987
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
488.2K
EBITDA
-13795074
Diluted EPS TTM
-2.12
Total Cash (MRQ)
13.7M
Current ratio (MRQ)
5.201
Operating Cash Flow (TTM)
-13444051
APRE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
